FindTrial
Sign In

Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis

Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024609
Enrollment
Unknown
Registered
2019-07-18
Start date
2014-02-03
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uremia

Interventions

dialysis group:Nil
non-dialysis group:Nil
Health people control group:Nil

Sponsors

Department of Nephrology, the Eleventh People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to 70 Years

Inclusion criteria

Inclusion criteria: uremic patients undergoing HD

Exclusion criteria

Exclusion criteria: (1) a history of surgery and trauma in the past three months; (2) presence of ischemic heart disease, cerebrovascular disease, blood disease, hepatitis, malignant weight, AIDS, and mental illness, or other similar conditions; (3) incomplete research data; (4) With acute infection in the past two weeks; (5) used hormones and immunosuppressants in the past six months; (6) used statins, levocarnitine and thiazolidinedione hypoglycemic agents in the past month.

Design outcomes

Primary

MeasureTime frame
IL-22;IL-10;CRP;TNF-alpha;IL-6;—

Countries

China

Contacts

Public ContactTingting Ren

Department of Nephrology, the Eleventh People's Hospital of Chengdu

r_rentingting@163.com+86 18328718525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026